Nov 04, 2019
Compugen Announces FDA Clearance of IND Application for COM902
Oct 22, 2019
Neurimmune Welcomes Biogen's News on Clinical Benefit of Aducanumab
Sep 24, 2019
Apexigen Announces Participation In Upcoming Oncology Conferences
Sep 16, 2019
Investigational Bispecific Therapeutic Antibodies: 2019 Landscape Evaluation Report
Sep 10, 2019
I-Mab Biopharma and Junshi Biosciences Announce Collaboration to Evaluate TJD5 in Combination with Toripalimab for the Treatment of Patients with Cancers in China
Aug 01, 2019
Oral Alpha-4-Beta-7 Integrin Antagonist PN-943 Demonstrates Sustained Dose-Related Target Engagement Activity in a Multiple Ascending Dose Phase 1 Study
Jul 17, 2019
Oblique Therapeutics has been Recognized as one of the 15 Most Promising Biotech Startups in Europe 2019, by StartUp City Magazine
Jun 28, 2019
BioAtla Appoints Eric Sievers, M.D., As Chief Medical Officer
Jun 18, 2019
Kleo Pharmaceuticals Announces a CD38 Targeting Antibody Recruiting Molecule (ARM(TM)) to Treat Multiple Myeloma as the First Clinical Candidate in its Partnership with PeptiDream
Jun 05, 2019
Aqualung Therapeutics Corporation Receives A $1.7 Million National Institute Of Health (NIH) Fastrack Award To Develop An Novel Immune-Based Therapeutic Antibody For Critically Ill Patients With Acute Lung Injury
Apr 23, 2019
ProMIS Neurosciences to Participate in the Think Equity Investor Conference
Apr 02, 2019
Agenus Begins Dosing with Next-Gen Anti-CTLA-4 Antibody
Apr 01, 2019
Apexigen Presents Clinical Data On CD40 Antibody APX005M In Metastatic Melanoma At The AACR Annual Meeting 2019
Mar 21, 2019
Agenus Announces Clinical Appointments
Mar 20, 2019
Apexigen Announces Clinical Data Presentations On CD40 Antibody APX005M At The AACR Annual Meeting 2019
Feb 19, 2019
CASI Pharmaceuticals Announces China National Medical Products Administration (NMPA) Approval Of CTA To Conduct Confirmatory Clinical Trial For ZEVALIN®
Feb 13, 2019
Innovent Announces First Patient Dosed in a Phase I Clinical Trial of an Anti-OX40 Antibody
Jan 18, 2019
Global Bispecific Antibody Market to 2025: Drug Sales & Clinical Pipeline Insights with an $8 Billion Market Opportunity
Jan 15, 2019
Inovio's dMAb(TM) PD-1 Checkpoint Inhibitors Demonstrate Higher and More Prolonged Expression Compared to Native Pembrolizumab and Nivolumab Sequences In Preclinical Studies
Jan 07, 2019
Adagene Announces Collaboration for Discovery of Novel CAR-T with the National Heart, Lung, and Blood Institute at the National Institute of Health (NIH)